Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia

Genes Chromosomes and Cancer

Volumn 46, Issue 5, 2007, Pages 478-486

  Barber, Kerry E ^a   Harrison, Christine J ^a   Broadfield, Zoe J ^a   Stewart, Adam R M ^a   Wright, Sarah L ^a   Martineau, Mary ^a   Strefford, Jon C ^a   Moorman, Anthony V ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LEUKEMIA; CHILD; CHROMOSOME 19P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 1; COHORT ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; GENE DELETION; GENE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PBX1 GENE; PRIORITY JOURNAL; SIGNAL DETECTION; TCF3 GENE; TUMOR SUPPRESSOR GENE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; LEUKEMIA, B-CELL, ACUTE; PRECANCEROUS CONDITIONS; SEQUENCE DELETION; TRANSLOCATION, GENETIC;

EID: 33947382184     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20431     Document Type: Article

References (33)

1. Bain G, Engel I. Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C. 1997. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17:4782-4791.
2. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-892.
3. Boomer T, Varella-Garcia M, McGavran L, Meltesen L, Olsen AS, Hunger SP. 2001. Detection of E2A translocations in leukemias via fluorescence in situ hybridization. Leukemia 15:95-102.
4. Brambillasca F, Mosna G, Colombo M, Rivolta A, Caslini C, Minuzzo M, Giudici G, Mizzi L, Biondi A, Privitera E. 1999. Identification of a novel molecular partner of the E2A gene in childhood leukemia. Leukemia 13:369-375.
5. Hann I, Vora A, Harrison G, Harrison C, Martineau M, Moorman AV, Seeker Walker LM, Eden O, Hill F, Gibson B, Richards S. 2001. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 113:103-114.
6. Harewood L, Robinson H, Harris R, Jabbar Al-Obaidi MS, Jalali GR, Martineau M, Moorman AV, Sumption N, Richards S, Mitchell C, Harrison CJ. 2003. Amplification of AML1 on a duplicated chromosome 21 in aute lymphoblastic leukemia: A study of 20 cases. Leukemia 17:547-553.
7. Harrison CJ, Martineau M, Secker-Walker LM. 2001. The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: A valuable resource for patient management. Br J Haematol 113:3-10.
8. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL, Jalali GR, Robinson HM, Strefford JC, Stewart A, Wright S, Griffiths M, Ross FM, Harewood L, Martineau M. 2005. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: A UK Cancer Cytogenetics Group Study. Br J Haematol 129:520-530.
9. Hunger SP, Zhong C. 2002. Cryptic t(12;19) in ALL with lineage switch to AML creates two new E2A fusion proteins. Blood 100:2070.
10. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT. 1992. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257: 531-534.
11. ISCN 2005. An International System for Human Cytogenetic Nomenclature. Shaffer LG, Tommerup N, editors. Basel: Karger.
12. Izraeli S, Janssen JWG, Haas OA, Harbott J, Brok-Simoni F, Walther JU, Kovar H, Henn T, Ludwig W-D, Reiter A, Rechavi G, Bartram CR, Gadner H, Lion T. 1993. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: A comparison between cytogenetic and polymerase chain reaction analyses. Leukemia 7:671-678.
13. Kamps MP, Murre C, Sun XH, Baltimore D. 1990. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547-555.
14. La Starza R, Aventin A, Crescenzi B, Gorello P, Specchia G, Cuneo A, Angioni A, Bilhou-Nabera C, Boque C, Foa R, Uyttebroeck A, Talmant P, Cimino G, Martelli MF, Marynen P, Mecucci C, Hagemeijer A. 2005. CIZ gene rearrangements in acute leukemia: Report of a diagnostic FISH assay and clinical features of nine patients. Leukemia 19:1696-1699.
15. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. 1990. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535-545.
16. Pallisgaard N, Hokland P, Riishoj DC, Pederson B, Jorgensen P. 1998. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 92:574-588.
17. Paulsson K, Horvat A, Fioretos T, Mitelman F, Johansson B. 2005. Formation of der(19)t(1;19)(q23;p13) in acute lymphoblastic leukemia. Genes Chromosomes Cancer 42:144-148.
18. Prima V, Gore L, Caires A, Boomer T, Yoshinari M, Imaizumi M, Varella-Garcia M, Hunger SP. 2005. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia. Leukemia 19:806-813.
19. Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D. 1992. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 79:1781-1788.
20. Privitera E, Luciano A, Ronchetti D, Arico M, Santostasi T, Basso G, Biondi A. 1994. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Leukemia 8:554-559.
21. Pui CH, Raimondi S, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH, Sabnlund JT, Crist WM, Behm FG. 1994. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 12:2601-2606.
22. Röttgers S, Brambillasca F, Giudici G, Harbott J, Privitera E, Biondi A. 2002. Heterozygous targeted disruption of E2A gene by an inv(19)(p13;q13) in childhood ALL. Blood 100:752A.
23. Röttgers S, Bungaro S, Privitera E, Biondi A, and Harbott J. 2003. Inversion inv(19)(p13q13) as the first chromsome aberration causing a heterozygous targeted disruption of an oncogene. Annales De Géné tique 46:106.
24. Seeker-Walker LM, Berger R, Fénaux P, Lai JL, Nelken B, Garson M, Michael PM, Hagemeijer A, Harrison CJ, Kaneko Y, Rubin CM. 1992. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 6:363-369.
25. Seeker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G. 1997. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol. 96:601-610.
26. Shearer BM, Flynn HC, Knudson RA, Ketterling RP. 2005. Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia. Br J Haematol 129: 45-52.
27. Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T, Lee E, Miller CW, Miyoshi I, Koeffler HP. 1995. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 55:5377-5383.
28. Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur DC, Lange BJ, Steinherz PG, Kraft P, Hutchinson R, Nachman JB, Reaman GH, Heerema NA. 1998. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: A report from the Children's Cancer Group. J Clin Oncol 16:527-535.
29. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K, Langerak AW, van Dongen JJ. 2004. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 18:895-908.
30. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y. 1997. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol 17:7317-7327.
31. Yoshinari M, Imaizumi M, Eguchi M, Ogasawara M, Saito T, Suzuki H, Koizumi Y, Cui Y, Sato A, Saisho T, Ichinohasama R, Matsubara Y, Kamada N, Iinuma K. 1998. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene. Cancer Genet Cytogenet 101:95-102.
32. Yuki Y, Imoto I, Imaizumi M, Hibi S, Kaneko Y, Amagasa T, Inazawa J. 2004. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci 95:503-507.
33. Zhuang Y, Soriano P, Weintraub H. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-884.